Trials / Completed
CompletedNCT02152969
Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)
An Open-label, Multiple-dose, Two-arm Clinical Study to Evaluate the Drug-drug Interaction and Safety of Telmisartan, Amlodipine and/or Chlorthalidone in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Yuhan Corporation · Industry
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To evaluate Drug-drug interaction
Detailed description
The purpose of this study is to evaluate the Drug-Drug(telmisartan, amlodipine and/ or chlorthalidone) interaction and safety in healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Telmisartan | |
| DRUG | Amlodipine | |
| DRUG | Chlorthalidone |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2014-08-01
- Completion
- 2014-11-01
- First posted
- 2014-06-02
- Last updated
- 2014-11-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02152969. Inclusion in this directory is not an endorsement.